论文部分内容阅读
司帕沙星是第4代喹诺酮类抗菌药物,该药抗菌活性强、抗菌谱广、半衰期长,使用方便。近年来,我们应用司帕沙星治疗细菌性泌尿道感染患者56例。报告如下。 临床资料:本组男39例,女17例;年龄31～87岁,平均(64.2±22.6)岁。其中单纯性泌尿道感染40例,复杂性泌尿道感染16例;患者均有如尿频、尿急、尿痛等表现,且中段尿培养阳性,尿镜检证实白细胞>10个/HP。无明显症状者相
Sparfloxacin is the fourth generation quinolone antibacterial drugs, the antibacterial activity of the drug, broad antibacterial spectrum, long half-life, easy to use. In recent years, we applied sparfloxacin in the treatment of bacterial urinary tract infections in 56 patients. The report is as follows. Clinical data: The group of 39 males and 17 females; aged 31 to 87 years, mean (64.2 ± 22.6) years old. Including simple urinary tract infection in 40 cases, complicated urinary tract infection in 16 cases; patients such as urinary frequency, urgency, dysuria and other performance, and urine culture positive, urinary microscopy confirmed white blood cells> 10 / HP. No obvious symptoms of phase